tiprankstipranks
Trending News
More News >
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market

Castle Biosciences (CSTL) Income Statement

Compare
450 Followers

Castle Biosciences Income Statement

Last quarter (Q3 2025), Castle Biosciences's total revenue was $83.04M, a decrease of -3.19% from the same quarter last year. In Q3, Castle Biosciences's net income was $-501.00K. See Castle Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 332.07M$ 219.79M$ 137.04M$ 94.08M$ 62.65M
Gross Profit
$ 271.86M$ 174.81M$ 105.03M$ 78.26M$ 52.96M
Operating Expenses
$ 263.19M$ 242.78M$ 177.88M$ 118.34M$ 59.51M
Depreciation and Amortization
$ 16.00M$ 12.33M$ 10.54M$ 3.41M$ 472.00K
EBITDA
$ 38.14M$ -45.02M$ -58.34M$ -36.60M$ -7.09M
Operating Income
$ 8.67M$ -67.98M$ -72.86M$ -40.08M$ -6.54M
Other Income/Expenses
$ 12.89M$ 10.61M$ 3.95M$ 67.00K$ -3.66M
Pretax Income
$ 21.56M$ -57.37M$ -68.90M$ -40.01M$ -10.20M
Net Income
$ 18.25M$ -57.47M$ -67.14M$ -31.29M$ -10.28M
Per Share Metrics
Basic EPS
$ 0.66$ -2.14$ -2.58$ -1.24$ -0.54
Diluted EPS
$ 0.62$ -2.14$ -2.58$ -1.24$ -0.54
Weighted Average Shares Outstanding
27.78M 26.80M 26.05M 25.14M 18.93M
Weighted Average Shares Outstanding (Diluted)
29.25M 26.80M 26.05M 25.14M 18.93M
Currency in USD

Castle Biosciences Earnings and Revenue History